SEC Form 4 research
| Issuer | Elicio Therapeutics, Inc. |
|---|---|
| Tickers | ELTX, ANG, ANGN |
| Reporting owners | 22 |
| Officers and directors | 8 |
| Last public filing | 2026-09-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-02 | 2026-08-31 | Chudnovsky Yekaterina | A | 21,750 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Ashe Carol Gail | A | 21,750 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Nissenson Allen | A | 21,750 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Venkatesan Jay | A | 21,750 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | WILSON KAREN J | A | 21,750 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | ADAMS JULIAN | A | 21,750 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | RUFFOLO ROBERT R | A | 21,750 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.